C4 Therapeutics (CCCC) Short Interest Ratio & Short Volume $4.05 -0.10 (-2.41%) (As of 11/20/2024 ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends C4 Therapeutics Short Interest DataC4 Therapeutics (CCCC) has a short interest of 5.85 million shares. This marks a -12.03% decrease in short interest from the previous month. The short interest ratio (days to cover) is 6.0, indicating that it would take 6.0 days of the average trading volume of 2.11 million shares to cover all short positions.Current Short Interest5,850,000 sharesPrevious Short Interest6,650,000 sharesChange Vs. Previous Month-12.03%Dollar Volume Sold Short$31.18 millionShort Interest Ratio6.0 Days to CoverLast Record DateOctober 31, 2024Outstanding Shares70,589,000 sharesPercentage of Shares Shorted8.29%Today's Trading Volume1,298,082 sharesAverage Trading Volume2,113,992 sharesToday's Volume Vs. Average61% Short Selling C4 Therapeutics? Sign up to receive the latest short interest report for C4 Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartCCCC Short Interest Over TimeCCCC Days to Cover Over TimeCCCC Percentage of Float Shorted Over Time Ad Crypto 101 MediaBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…YES, I WANT THE #1 CRYPTO NOW C4 Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/31/20245,850,000 shares $31.18 million -12.0%N/A6 $5.33 10/15/20246,650,000 shares $41.90 million -39.6%N/A6.7 $6.30 9/30/202411,010,000 shares $62.76 million -7.6%N/A9 $5.70 9/15/202411,920,000 shares $76.76 million +2.5%N/A8.1 $6.44 8/31/202411,630,000 shares $73.50 million +10.8%N/A7.4 $6.32 8/15/202410,500,000 shares $61.53 million +0.3%N/A6.6 $5.86 Get the Latest News and Ratings for CCCC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for C4 Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 7/31/202410,470,000 shares $70.15 million -10.0%N/A6.3 $6.70 7/15/202411,630,000 shares $75.48 million +32.0%N/A7 $6.49 6/30/20248,810,000 shares $40.70 million -39.4%N/A5.7 $4.62 6/15/202414,540,000 shares $63.69 million +9.7%N/A10.2 $4.38 5/31/202413,260,000 shares $66.30 million +16.9%N/A8.4 $5.00 5/15/202411,340,000 shares $69.29 million +11.8%N/A5.9 $6.11 4/30/202410,140,000 shares $63.88 million +6.1%N/A4.5 $6.30 4/15/20249,560,000 shares $65.58 million +4.5%N/A3.7 $6.86 3/31/20249,150,000 shares $74.76 million +73.0%N/A2.4 $8.17 3/15/20245,290,000 shares $47.24 million +78.1%N/A1.1 $8.93 2/29/20242,970,000 shares $32.61 million -6.6%N/A0.2 $10.98 2/15/20243,180,000 shares $25.12 million -5.1%N/A0.2 $7.90 1/31/20243,350,000 shares $20.70 million -39.6%8.7%0.2 $6.18 1/15/20245,550,000 shares $37.74 million +22.3%14.5%0.4 $6.80 12/31/20234,540,000 shares $25.65 million -44.0%10.8%0.3 $5.65 12/15/20238,100,000 shares $40.10 million +330.9%19.3%0.7 $4.95 11/30/20231,880,000 shares $3.06 million -3.6%4.5%3.4 $1.63 11/15/20231,950,000 shares $3.51 million +2.1%4.7%4.1 $1.80 10/31/20231,910,000 shares $2.85 million +4.4%4.6%3.9 $1.49 10/15/20231,830,000 shares $3.64 million -19.0%4.6%3.8 $1.99 9/30/20232,260,000 shares $4.20 million -5.0%5.6%5.2 $1.86 9/15/20232,380,000 shares $5.31 million +14.4%5.9%2.4 $2.23 8/31/20232,080,000 shares $6.03 million +9.5%5.2%1.9 $2.90 8/15/20231,900,000 shares $6.42 million -10.0%4.7%1.6 $3.38 7/31/20232,110,000 shares $8.21 million -5.8%5.3%1.7 $3.89 7/15/20232,240,000 shares $7.50 million -8.9%5.6%1.8 $3.35 6/30/20232,460,000 shares $6.77 million -26.4%6.1%2 $2.75 6/15/20233,340,000 shares $12.06 million +2.8%8.3%5.1 $3.61 5/31/20233,250,000 shares $11.02 million +12.1%8.1%5.4 $3.39 5/15/20232,900,000 shares $9.69 million +0.7%7.2%5.2 $3.34 4/30/20232,880,000 shares $8.70 million +1.8%7.0%5 $3.02 4/15/20232,830,000 shares $9.48 million +7.6%6.9%4.9 $3.35 3/31/20232,630,000 shares $8.26 million -9.9%6.5%4.5 $3.14 3/15/20232,920,000 shares $12.59 million -10.2%7.2%5.1 $4.31Trump said you could learn something from this man (Ad)Early Warning: A Deep Crack Is Forming In The US Economy Stocks are booming thanks to Trump’s landslide victory. Yet one former Trump advisor says the picture is less rosy than it seems. “I’ve found a deep crack forming in the foundations of the US economy,” he says. “And before too long, it could tear our country apart.” It’s critical you learn more today, BEFORE it impacts your money and your retirement. Here’s everything you need to know. 2/28/20233,250,000 shares $17.13 million +0.9%8.0%6.3 $5.27 2/15/20233,220,000 shares $18.58 million -12.5%7.9%6.1 $5.77 1/31/20233,680,000 shares $28.67 million +2.8%9.0%7 $7.79 1/15/20233,580,000 shares $30.57 million +2.0%8.8%7.8 $8.54 12/30/20223,510,000 shares $20.71 million -3.6%8.6%7.8 $5.90 12/15/20223,640,000 shares $29.48 million +0.3%8.9%8 $8.10 11/30/20223,630,000 shares $31.11 million -8.1%8.9%7.5 $8.57 11/15/20223,950,000 shares $38.39 million -19.1%9.7%8.5 $9.72 10/31/20224,880,000 shares $46.95 million -1.2%11.9%11.4 $9.62 10/15/20224,940,000 shares $39.32 million -2.0%12.9%12.1 $7.96 9/30/20225,040,000 shares $44.20 million +11.0%13.2%11.9 $8.77 9/15/20224,540,000 shares $51.57 million -6.8%11.8%9.8 $11.36 8/31/20224,870,000 shares $49.09 million -5.1%12.7%9.9 $10.08 8/15/20225,130,000 shares $62.23 million -3.2%13.4%9.2 $12.13 7/31/20225,300,000 shares $51.09 million +1.5%13.9%8.2 $9.64 7/15/20225,220,000 shares $52.30 million +2.8%13.7%7.2 $10.02 6/30/20225,080,000 shares $38.30 million +20.7%13.3%4.7 $7.54 6/15/20224,210,000 shares $23.11 million -2.1%11.0%3.7 $5.49 5/31/20224,300,000 shares $31.22 million +10.3%11.3%4.2 $7.26 5/15/20223,900,000 shares $27.89 million -23.7%10.2%3.9 $7.15 4/30/20225,110,000 shares $43.79 million -4.7%13.4%5.4 $8.57 4/15/20225,360,000 shares $47.97 million +4.7%14.0%5.8 $8.95 3/31/20225,120,000 shares $124.21 million +8.5%13.4%7.2 $24.26 3/15/20224,720,000 shares $101.48 million +29.7%12.4%9.8 $21.50 2/28/20223,640,000 shares $81.65 million +8.7%9.5%7.6 $22.43 2/15/20223,350,000 shares $80.03 million +23.2%8.8%7.7 $23.89 1/31/20222,720,000 shares $66.45 million -13.1%7.1%6.7 $24.43 1/15/20223,130,000 shares $86.20 million -1.6%8.1%9.5 $27.54 12/31/20213,180,000 shares $102.40 million +6.0%8.3%10.9 $32.20 12/15/20213,000,000 shares $91.50 million +8.3%7.8%11 $30.50 11/30/20212,770,000 shares $102.82 million +0.4%7.2%10.6 $37.12 11/15/20212,760,000 shares $115.09 million +2.2%7.2%10.3 $41.70 10/29/20212,700,000 shares $119.93 million +1.5%7.0%9.9 $44.42 10/15/20212,660,000 shares $116.75 million No Change6.9%8.7 $43.89 9/30/20212,660,000 shares $118.85 million +17.2%6.9%7.9 $44.68 9/15/20212,270,000 shares $110.75 million -6.2%5.9%5.7 $48.79 8/31/20212,420,000 shares $97.11 million -11.7%6.6%5.5 $40.13 8/13/20212,740,000 shares $107.82 million +3.4%7.4%6 $39.35 7/30/20212,650,000 shares $114.32 million No Change8.1%5.5 $43.14 7/15/20212,650,000 shares $98.90 million -5.0%8.1%5.8 $37.32 6/30/20212,790,000 shares $105.57 million +18.2%8.5%6 $37.84 6/15/20212,360,000 shares $88.88 million -3.7%7.2%5.5 $37.66 5/28/20212,450,000 shares $90.53 million -7.9%7.4%6.4 $36.95 5/14/20212,660,000 shares $90.60 million +1.9%8.0%7.7 $34.06 4/30/20212,610,000 shares $89.37 million -12.1%7.9%8.6 $34.24 4/15/20212,970,000 shares $98.54 million -19.1%9.0%10.3 $33.18 3/31/20213,670,000 shares $120.74 million +77.3%11.1%13.8 $32.90 3/15/20212,070,000 shares $92.40 million +6.7%6.4%8 $44.64 2/26/20211,940,000 shares $81.00 million +21.3%5.9%7.7 $41.75 2/12/20211,600,000 shares $72.86 million +3.9%4.8%5.5 $45.54Trump said you could learn something from this man (Ad)Early Warning: A Deep Crack Is Forming In The US Economy Stocks are booming thanks to Trump’s landslide victory. Yet one former Trump advisor says the picture is less rosy than it seems. “I’ve found a deep crack forming in the foundations of the US economy,” he says. “And before too long, it could tear our country apart.” It’s critical you learn more today, BEFORE it impacts your money and your retirement. Here’s everything you need to know. 1/29/20211,540,000 shares $55.70 million -14.9%4.4%3.9 $36.17 1/15/20211,810,000 shares $68.73 million No Change5.2%3.8 $37.97 CCCC Short Interest - Frequently Asked Questions What is C4 Therapeutics' current short interest? Short interest is the volume of C4 Therapeutics shares that have been sold short but have not yet been closed out or covered. As of October 31st, investors have sold 5,850,000 shares of CCCC short. Learn More on C4 Therapeutics' current short interest. What is a good short interest ratio for C4 Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CCCC shares currently have a short interest ratio of 6.0. Learn More on C4 Therapeutics's short interest ratio. Is C4 Therapeutics' short interest increasing or decreasing? C4 Therapeutics saw a decline in short interest in October. As of October 31st, there was short interest totaling 5,850,000 shares, a decline of 12.0% from the previous total of 6,650,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does C4 Therapeutics' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to C4 Therapeutics: Alector, Inc. (6.24%), Inhibrx, Inc. (9.70%), Compugen Ltd. (1.42%), Applied Therapeutics, Inc. (10.43%), Avadel Pharmaceuticals plc (9.82%), Cogent Biosciences, Inc. (7.63%), Bicycle Therapeutics plc (6.88%), Collegium Pharmaceutical, Inc. (19.87%), Phibro Animal Health Co. (2.03%), Immatics (5.61%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks. What does it mean to sell short C4 Therapeutics stock? Short selling CCCC is an investing strategy that aims to generate trading profit from C4 Therapeutics as its price is falling. CCCC shares are trading down $0.10 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against C4 Therapeutics? A short squeeze for C4 Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of CCCC, which in turn drives the price of the stock up even further. How often is C4 Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CCCC, twice per month. The most recent reporting period available is October, 31 2024. More Short Interest Resources from MarketBeat Related Companies ALEC Short Interest INBX Short Interest CGEN Short Interest APLT Short Interest AVDL Short Interest COGT Short Interest BCYC Short Interest COLL Short Interest PAHC Short Interest IMTX Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:CCCC) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding C4 Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share C4 Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CCCC Stock Alerts